Association Between Single-nucleotide Polymorphisms of Selected Genes Involved in the Response to DNA Damage and Risk of Colon, Head and Neck, and Breast Cancers in a Polish Population

Overview

Journal J Appl Genet

Publisher Springer

Specialty Genetics

Date 2010 Aug 20

PMID 20720310

Citations 61

Authors

K Jelonek

A Gdowicz-Klosok

M Pietrowska

M Borkowska

J Korfanty

J Rzeszowska-Wolny

P Widlak

Affiliations

Soon will be listed here.

Abstract

Single-nucleotide polymorphisms in genes involved in DNA-damage-induced responses are reported frequently to be a risk factor in various cancer types. Here we analysed polymorphisms in 5 genes involved in DNA repair (XPD Asp312Asn and Lys751Gln, XRCC1 Arg399Gln, APE1 Asp148Glu, NBS1 Glu185Gln, and XPA G-4A) and in a gene involved in regulation of the cell-cycle (CCND1 A870G). We compared their frequencies in groups of colon, head and neck, and breast cancer patients, and 2 healthy control groups: (1) matched healthy Polish individuals and (2) a NCBI database control group. Highly significant differences in the distribution of genotypes of the APE1, XRCC1 and CCND1 genes were found between colon cancer patients and healthy individuals. The 148Asp APE1 allele and the 399Gln XRCC1 allele apparently increased the risk of colon cancer (OR = 1.9-2.3 and OR = 1.5-2.1, respectively). Additionally, frequencies of XPD genotypes differed between healthy controls and patients with colon or head and neck cancer. Importantly, no differences in the distribution of these polymorphisms were found between healthy controls and breast cancer patients. The data clearly indicate that the risk of colon cancer is associated with single-nucleotide polymorphism in genes involved in base-excision repair and DNA-damage-induced responses.

Citing Articles

Association of ERCC2/XPD polymorphisms and the risk of head and neck carcinoma: a systematic review, meta-analysis, trial sequential analysis, network analysis, and functional effects.

Imani M, Ashabi A, Rezaei F, Saffar Shahroudi A, Kashkouli S, Sadeghi E BMC Oral Health. 2025; 25(1):201.

PMID: 39923044 PMC: 11806812. DOI: 10.1186/s12903-025-05476-7.

Revealing the causal role of immune cells in malignant neoplasms of the head and neck: insights from Mendelian randomization.

Zhou E, Yuan M, Zhong J, Xiao X Front Oncol. 2024; 14:1435313.

PMID: 39678507 PMC: 11638183. DOI: 10.3389/fonc.2024.1435313.

Relationship between , , , and Polymorphisms and the Susceptibility to Head and Neck Carcinoma: A Systematic Review, Meta-Analysis, and Trial Sequential Analysis.

Imani M, Basamtabar M, Akbari S, Sadeghi E, Sadeghi M Medicina (Kaunas). 2024; 60(3).

PMID: 38541204 PMC: 10972270. DOI: 10.3390/medicina60030478.

R194W and R399Q Polymorphisms and Colorectal Cancer Risk in a Northeastern Mexican Population.

Meza-Espinoza J, Peralta-Leal V, Duran-Gonzalez J, Macias-Gomez N, Bocanegra-Alonso A, Leal-Ugarte E Genet Res (Camb). 2023; 2023:5565646.

PMID: 37829155 PMC: 10567464. DOI: 10.1155/2023/5565646.

Gene polymorphisms and risk of head and neck squamous cell carcinoma: a systematic review.

Rajabi-Moghaddam M, Abbaszadeh H Rep Pract Oncol Radiother. 2023; 27(6):1058-1076.

PMID: 36632298 PMC: 9826653. DOI: 10.5603/RPOR.a2022.0115.

References

Huang Y, Li L, Yu L . XRCC1 Arg399Gln, Arg194Trp and Arg280His polymorphisms in breast cancer risk: a meta-analysis. Mutagenesis. 2009; 24(4):331-9. DOI: 10.1093/mutage/gep013. View

Improta G, Sgambato A, Bianchino G, Zupa A, Grieco V, La Torre G . Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population. Anticancer Res. 2008; 28(5B):2941-6. View

Sliwinski T, Krupa R, Wisniewska-Jarosinska M, Pawlowska E, Lech J, Chojnacki J . Common polymorphisms in the XPD and hOGG1 genes are not associated with the risk of colorectal cancer in a Polish population. Tohoku J Exp Med. 2009; 218(3):185-91. DOI: 10.1620/tjem.218.185. View

Misra R, Ratnasinghe D, Tangrea J, Virtamo J, Andersen M, Barrett M . Polymorphisms in the DNA repair genes XPD, XRCC1, XRCC3, and APE/ref-1, and the risk of lung cancer among male smokers in Finland. Cancer Lett. 2003; 191(2):171-8. DOI: 10.1016/s0304-3835(02)00638-9. View

Excoffier L, Laval G, Schneider S . Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online. 2009; 1:47-50. PMC: 2658868. View

Hu J, Smith T, Miller M, Mohrenweiser H, Golden A, Case L . Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis. 2001; 22(6):917-22. DOI: 10.1093/carcin/22.6.917. View

Varon R, Vissinga C, Platzer M, Cerosaletti K, Chrzanowska K, Saar K . Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell. 1998; 93(3):467-76. DOI: 10.1016/s0092-8674(00)81174-5. View

Rydzanicz M, Golusinski P, Mielcarek-Kuchta D, Golusinski W, Szyfter K . Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx. Eur Arch Otorhinolaryngol. 2005; 263(1):43-8. DOI: 10.1007/s00405-005-0957-7. View

Betticher D, Thatcher N, Altermatt H, Hoban P, Ryder W, Heighway J . Alternate splicing produces a novel cyclin D1 transcript. Oncogene. 1995; 11(5):1005-11. View

10.

Lopez-Cima M, Gonzalez-Arriaga P, Garcia-Castro L, Pascual T, Marron M, Puente X . Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. BMC Cancer. 2007; 7:162. PMC: 2020474. DOI: 10.1186/1471-2407-7-162. View

11.

Paz-Elizur T, Sevilya Z, Leitner-Dagan Y, Elinger D, Roisman L, Livneh Z . DNA repair of oxidative DNA damage in human carcinogenesis: potential application for cancer risk assessment and prevention. Cancer Lett. 2008; 266(1):60-72. PMC: 2563153. DOI: 10.1016/j.canlet.2008.02.032. View

12.

Moreno V, Gemignani F, Landi S, Gioia-Patricola L, Chabrier A, Blanco I . Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res. 2006; 12(7 Pt 1):2101-8. DOI: 10.1158/1078-0432.CCR-05-1363. View

13.

Goode E, Ulrich C, Potter J . Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev. 2002; 11(12):1513-30. View

14.

Jiricny J, Marra G . DNA repair defects in colon cancer. Curr Opin Genet Dev. 2003; 13(1):61-9. DOI: 10.1016/s0959-437x(03)00004-2. View

15.

Kowalski M, Przybylowska K, Rusin P, Olszewski J, Morawiec-Sztandera A, Bielecka-Kowalska A . Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck. J Exp Clin Cancer Res. 2009; 28:37. PMC: 2660298. DOI: 10.1186/1756-9966-28-37. View

16.

Ziolkowska I, Mosor M, Wierzbicka M, Rydzanicz M, Pernak-Schwarz M, Nowak J . Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene. Cancer Sci. 2007; 98(11):1701-5. PMC: 11158328. DOI: 10.1111/j.1349-7006.2007.00594.x. View

17.

Spitz M, Wu X, Wang Y, Wang L, Shete S, Amos C . Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res. 2001; 61(4):1354-7. View

18.

De Ruyck K, Szaumkessel M, De Rudder I, Dehoorne A, Vral A, Claes K . Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat Res. 2007; 631(2):101-10. DOI: 10.1016/j.mrgentox.2007.03.010. View

19.

Li H, Ha T, Tai B . XRCC1 gene polymorphisms and breast cancer risk in different populations: a meta-analysis. Breast. 2009; 18(3):183-91. DOI: 10.1016/j.breast.2009.03.008. View

20.

Kong S, Amos C, Luthra R, Lynch P, Levin B, Frazier M . Effects of cyclin D1 polymorphism on age of onset of hereditary nonpolyposis colorectal cancer. Cancer Res. 2000; 60(2):249-52. View